Evidence map›Paper›PMID 10545130›Full record

ArticleThe Journal of physiology1999

Gating of G protein-sensitive inwardly rectifying K+ channels through phosphatidylinositol 4,5-bisphosphate.

D E Logothetis, H Zhang

Open access · greenAbstract readComment
In one paragraph

Article in The Journal of physiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Kisspeptin excitation of GnRH neurons.Advances in experimental medicine and biology · 2013
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Interplay between PIP3 and calmodulin regulation of olfactory cyclic nucleotide-gated channels.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  12. Article
  13. Article
  14. Graded contribution of the Gbeta gamma binding domains to GIRK channel activation.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

D E LogothetisDepartment of Physiology and Biophysics, Mount Sinai School of Medicine, New York University, New York, NY 10029, USA.
H Zhang
Icahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several inwardly rectifying K+ channels show an ATP-dependent rundown of their activity. Hydrolysis of ATP is required for maintenance of channel activity. G protein-gated inwardly rectifying K+ (GIRK) channels also depend on ATP hydrolysis for gating by sodium ions or the [beta][gamma] subunits of G proteins (Sui et al. 1998). Strong evidence suggests that phosphatidylinositol 4, 5-bisphosphate (PIP2), synthesized via the hydrolysis of ATP, is absolutely required for channel gating (Sui et al. 1998; Huang et al. 1998). Interestingly, Huang and colleagues (Huang et al. 1998) showed that G[beta][gamma] subunits (the [beta][gamma] subunits of GTP-binding proteins) caused a stabilization of channel-PIP2 interactions, suggesting that G[beta][gamma] subunits may gate the channel through PIP2. Ho & Murrell-Lagnado (1999b) recently identified an aspartate residue responsible for gating these K+ channels. Ho & Murrell-Lagnado (1999a) in this issue of The Journal of Physiology present evidence that sodium ions also stabilize channel-PIP2 interactions. They suggest that Na+ effectively neutralizes a negatively charged residue, somehow promoting interactions of the channel with PIP2. These results on the mechanism of Na+ action are in close agreement with recently published work from our group. Zhang et al. (1999) showed that two C-terminal cytoplasmic arginine residues, which interact with PIP2, are localized next to the identified aspartate residue that is responsible for the Na+ effects on gating. Thus, the implication from the results of these three studies (Huang et al. 1998; Zhang et al. 1999; Ho & Murrell-Lagnado, 1999a) is that stabilization of channel-PIP2 interactions may be a common mechanism for gating GIRK channels by molecules as different as Na+ or the G[beta][gamma] subunits (see Fig. 1). These results raise many interesting questions on how modulation of channel-PIP2 interactions may lead to channel gating. Are the channel-PIP2 sites that are stabilized by G[beta][gamma] subunits shared with those that are affected by Na+? Na+ seems to act by screening the electrostatic effects that the aspartate residue exerts on the nearby PIP2-interacting arginines. How does G[beta][gamma] binding lead to stabilization of channel- PIP2 interactions? Is the Na+ sensitivity of the channel used physiologically and if so how does it relate to signalling through G proteins? Structural data for these channels and in particular for their cytoplasmic portions, which are critical for interactions with PIP2, will greatly aid our molecular understanding of the conformations needed for channel gating. Finally, although the dependence of GIRK channel activity on PIP2 is clear, it is not known yet whether the levels of PIP2 needed for channel gating are constant or under regulatory control. Answers to these and many other such questions are likely to shed light on the mechanism by which PIP2 itself serves as an important regulator of the activity of membrane proteins.

Indexed as

Potassium Channels, Inwardly RectifyingIon Channel GatingPhosphatidylinositol 4,5-DiphosphatePotassium ChannelsPhosphatidylinositol 4,5-DiphosphatePotassium ChannelsPotassium Channels, Inwardly Rectifying

Identifiers

PMID10545130
PMCPMC2269611
OpenAlexW1988475865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.